Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
24.36
-0.67 (-2.68%)
At close: Sep 3, 2026, 4:00 PM EDT
24.40
+0.04 (0.16%)
Pre-market: Sep 4, 2026, 7:38 AM EDT
Pelthos Therapeutics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Pelthos Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $53.14. The average 1-year stock price forecast is 118.14% higher than the current stock price, while the lowest is $45 (+84.73%) and the highest is $64 (+162.73%).
Price Target: $53.14 (+118.14%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Pelthos Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Buy Reiterates $45 | Buy | Reiterates | $45 | +84.73% | Aug 31, 2026 |
| Lake Street | Lake Street | Buy Maintains $50 | Buy | Maintains | $50 | +105.25% | Aug 14, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $48 | Buy | Reiterates | $48 | +97.04% | Aug 14, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $66 → $64 | Buy | Reiterates | $66 → $64 | +162.73% | Aug 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +146.31% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
63.75M
from 16.80M
Increased by 279.56%
Revenue Next Year
112.22M
from 63.75M
Increased by 76.03%
EPS This Year
-18.82
from -13.29
EPS Next Year
-5.68
from -18.82
EPS and Forward PE are based on non-GAAP adjusted numbers.